Kate Gilling

Associate Director Clinical Development DACH, ITF Pharma GmbH

Kate Gilling is listed as Associate Director Clinical Development DACH, ITF Pharma GmbH. Kate spoke at DGN Kongress 2026 (Kongress der Deutschen Gesellschaft für Neurologie) in November 2026 (speaker, “Erkrankungen von Rückenmark, Nerv & Muskel I”).

Compiled from published conference agendas; not yet confirmed by Kate. Is this you? Claim this profile.

Sessions at 1 conference